Longevity Health Holdings Inc.
XAGE · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $50 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $6 | $125 | $243 | $0 |
| Gross Profit | $44 | -$125 | -$243 | $0 |
| % Margin | 87.4% | – | – | – |
| R&D Expenses | $1,054 | $2,497 | $2,196 | $983 |
| G&A Expenses | $3,715 | $0 | $3,217 | $863 |
| SG&A Expenses | $3,905 | $2,595 | $3,217 | $863 |
| Sales & Mktg Exp. | $189 | $0 | $0 | $0 |
| Other Operating Expenses | $83 | $0 | -$148 | $94 |
| Operating Expenses | $5,042 | $5,092 | $5,265 | $1,940 |
| Operating Income | -$4,998 | -$5,217 | -$5,508 | -$467 |
| % Margin | -9,933.8% | – | – | – |
| Other Income/Exp. Net | -$5,749 | -$10,988 | -$3,544 | $138 |
| Pre-Tax Income | -$10,748 | -$16,205 | -$9,051 | -$329 |
| Tax Expense | -$97 | $0 | $0 | $0 |
| Net Income | -$10,368 | -$15,445 | -$9,051 | -$6,479 |
| % Margin | -20,605.5% | – | – | – |
| EPS | -0.5 | -0.74 | -0.5 | -0.011 |
| % Growth | 32.4% | -48% | -4,487.2% | – |
| EPS Diluted | -0.5 | -0.74 | -0.5 | -0.011 |
| Weighted Avg Shares Out | 20,905 | 20,772 | 19,769 | 19,769 |
| Weighted Avg Shares Out Dil | 20,905 | 20,772 | 19,769 | 19,769 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $2,248 | $8 |
| Interest Expense | $49 | $889 | $3,749 | $2,499 |
| Depreciation & Amortization | $197 | $125 | $243 | $242 |
| EBITDA | -$10,501 | -$15,191 | -$5,060 | -$87 |
| % Margin | -20,870.2% | – | – | – |